Which action reduces risk by limiting access to high-alert drugs?

Which action reduces risk by limiting access to high-alert drugs?

• A. Limit access to these drugs.
• B. Use special labels for these drugs.
• C. Provide increased information to staff.
• D. Standardize the ordering and preparation of these drugs.

Answer: (A)

Limiting access to high-alert medications reduces risk by creating a barrier between the drug and people who might mishandle it. When only authorized staff can obtain or handle these drugs and they’re kept in secure, controlled locations, there are fewer opportunities for wrong drug selection, diversion, or inappropriate preparation and administration. This direct control of who and how the drug can be accessed is a powerful way to prevent errors and patient harm. Labels, while helpful for recognition, do not by themselves restrict access. Providing more information to staff improves knowledge and awareness but doesn’t prevent unauthorized handling. Standardizing ordering and preparation reduces variability and errors in processes, yet it still relies on access existing for the staff who perform those steps; it doesn’t inherently limit who can reach the drug.

Limiting access to high-alert medications reduces risk by creating a barrier between the drug and people who might mishandle it. When only authorized staff can obtain or handle these drugs and they’re kept in secure, controlled locations, there are fewer opportunities for wrong drug selection, diversion, or inappropriate preparation and administration. This direct control of who and how the drug can be accessed is a powerful way to prevent errors and patient harm.

Labels, while helpful for recognition, do not by themselves restrict access. Providing more information to staff improves knowledge and awareness but doesn’t prevent unauthorized handling. Standardizing ordering and preparation reduces variability and errors in processes, yet it still relies on access existing for the staff who perform those steps; it doesn’t inherently limit who can reach the drug.